title: [Successful treatment of metastatic testicular tumor of extreme size].
abstract: Testicular cancer is the most common cancer in young males. Testicular cancer has one of the highest cure rates of all cancers: with modern chemotherapy treatment five-year survival rate exceeds 90 percent overall, and reaches almost 100 percent in early stages. However, these favorable results can only be achieved if these patients are transferred to a reference center, because better outcome was reported for patients who had been treated in a high volume center. Strict adherence to therapeutic protocol is vital for good results. We present a case of a testicular cancer patient with very advanced disease and poor performance status, who was deemed incurable by another oncological center. We achieved complete remission by strictly adhering to the protocol, and using all the available supportive measures. We would like to demonstrate the difficulties we were facing while treating this poor prognostic patient.
authors.affiliation: C Belgyógyászati-Onkológiai és Klinikai Farmakológiai Osztály, Országos Onkológiai Intézet, Budapest, Hungary. kuronyaz@gmail.com.
authors.forename: Zsófia
authors.initials: Z
authors.lastname: Küronya
authors.affiliation: C Belgyógyászati-Onkológiai és Klinikai Farmakológiai Osztály, Országos Onkológiai Intézet, Budapest, Hungary. kuronyaz@gmail.com.
authors.forename: Hajnalka
authors.initials: H
authors.lastname: Németh
authors.affiliation: C Belgyógyászati-Onkológiai és Klinikai Farmakológiai Osztály, Országos Onkológiai Intézet, Budapest, Hungary. kuronyaz@gmail.com.
authors.forename: Lajos
authors.initials: L
authors.lastname: Géczi
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D003863:Depression / Q000209:etiology; D018450:Disease Progression; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects; D064147:Febrile Neutropenia / Q000139:chemically induced; D006801:Humans; D033183:Interdisciplinary Communication; D008297:Male; D008875:Middle Aged; D009919:Orchiectomy; D010348:Patient Care Team; D011379:Prognosis; D011788:Quality of Life; D012074:Remission Induction / Q000379:methods; D013226:Status Epilepticus / Q000139:chemically induced; D013736:Testicular Neoplasms / Q000188:drug therapy* / Q000473:pathology* / Q000523:psychology / Q000601:surgery; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000139:chemically induced
chemical_list: D001761:Bleomycin; D005047:Etoposide; D002945:Cisplatin